article thumbnail

At ASH, doctors acclaim new sickle cell gene therapies, but are cautious on details

Bio Pharma Dive

Uptake of Casgevy and Lyfgenia may be slow despite their dramatic benefit, physicians said, citing complexities in treatment, manufacturing and reimbursement.

article thumbnail

Doctor invents hybrid mask allowing ENT doctors to see more patients

Scienmag

VA seeking companies to license, manufacture Credit: Dr. Scott Fuller/VA SACRAMENTO, Calif. – An ear, nose, and throat doctor has invented a simple mask design that significantly improves safety during aerosol-generating procedures of the head and neck.

Doctors 95
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA and doctors warn against extending COVID-19 vaccine dose gap

pharmaphorum

In the US, doctors pointed out that the slow roll-out of the vaccines is due to logistical challenges rather than supply and urged authorities to focus on this rather than delaying the dosing schedule. Several million more doses of the vaccine are understood to have been manufactured but have not yet been bottled in vials.

Doctors 126
article thumbnail

Low-tech – just what the doctor ordered

Scienmag

Low-tech – just what the doctor ordered Credit: University of Leeds/Dr Pete Culmer Low-tech – just what the doctor ordered Medical equipment that can be manufactured at low cost, is simple to use and can be easily maintained will help extend surgery to the 5 billion people worldwide who currently cannot get access to it, […].

Doctors 82
article thumbnail

DOJ cracks down on 'largest and most wide-ranging' COVID-19 fraud

Bio Pharma Dive

Defendants, including doctors, medical business executives and fake vaccination card manufacturers, caused nearly $150 million in false billings to federal programs, the DOJ said.

Doctors 139
article thumbnail

Top 30 New Medical Devices of 2024

XTalks

TriClip G4 System Manufacturer/developer : Abbott Medical Date of FDA approval : April 1, 2024 Approved for : Tricuspid regurgitation (TR). Abbott Spinal Cord Stimulation (SCS) Systems Manufacturer/developer : Abbott Medical Date of FDA approval : May 30, 2024 Approved for : Chronic, hard-to-manage pain in the torso, arms and legs.

article thumbnail

FDA turns down Outlook's ophthalmic version of Roche's Avastin over manufacturing, data shortfalls

Fierce Pharma

Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases.